Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Protective Efficacy of Oral Recombinant Subunit B/Bacterial Cholera Vaccine (Enteric-coated Capsules) Against Infectious Diarrhea Caused by Non-Vibrio Cholerae in Healthy People Aged 2 to 14 Years

NCT07300462 is registered in ClinicalTrials.gov with Shanghai United Cell Biotechnology Co., Ltd as lead sponsor.

NCT NCT07300462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07300462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Protective Efficacy of Oral Recombinant Subunit B/Bacterial Cholera Vaccine (Enteric-coated Capsules) Against Infectious Diarrhea Caused by Non-Vibrio Cholerae in Healthy People Aged 2 to 14 Years
Lead sponsor
Shanghai United Cell Biotechnology Co., Ltd
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 10, 2026
Completion date
January 31, 2027
Enrollment
6,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea